Pancreatic Cancer Research

ResearcherUniversity of OuluNo recent work listed

Tuomo J. Karttunen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8843-7957; OpenAlex author ID A5077468190. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: 2 papers

Papers 4

  1. Immune cell score in pancreatic cancer-comparison of hotspot and whole-section techniques. Co-author DOI 10.1007/s00428-019-02549-1↗
  2. Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000001195↗
  3. Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma. Last author DOI 10.1186/s12957-018-1432-4↗
  4. High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patients. Last author DOI 10.1007/s00428-017-2087-1↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Joni Leppänen · 4 shared papers, 2017–2019 · strength 0.33
  2. Kirsi‐Maria Haapasaari · 4 shared papers, 2017–2019 · strength 0.33
  3. Joel Isohookana · 3 shared papers, 2017–2019 · strength 0.24
  4. Joonas H. Kauppila · 3 shared papers, 2017–2019 · strength 0.24
  5. Heikki I. Huhta · 3 shared papers, 2017–2019 · strength 0.24
  6. Ilmo Kellokumpu · 1 shared paper, 2019 · strength 0.10
  7. Jan Böhm · 1 shared paper, 2019 · strength 0.10
  8. Kyösti Tahkola · 1 shared paper, 2019 · strength 0.10
  9. Peeter Karihtala · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.